Back to search

Netherlands· NL-a352dd52d0ee

Chloortalidon Glenmark 25 mg tabletten

A chlortalidone product containing chloortalidon, registered in Netherlands by Glenmark Arzneimittel GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC C03BA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedChloortalidon Glenmark 25 mg tablettenATCC03BA04REGISTER NO.NL-a352dd52d0eePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Chlortalidone is registered in 11 of 19 countries.

Countries holding a registration under ATC C03BA04 (chlortalidone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Chlortalidone · ATC C03BA04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chlortalidone costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.40 in Switzerland to $5.90 in United States — a ×15 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Chlortalidone · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • US United States$5.90 (acquisition cost)
  • CH Switzerland$0.40
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CHLOORTALIDON
Manufacturer
Glenmark Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
C03BA04
ATC class
Chlortalidone
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131381

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

264 interactions on record for chlortalidone.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chlortalidone · interactions on record

264 records

  • 4 severe
  • 208 moderate
  • 19 minor
  • 29 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Aminolevulinic acidL01XD04severe
  • Arsenic trioxideL01XX27severe

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chlortalidone in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlortalidone products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Hydrosan, Uldiulan
  • Belgium · Hygroton
  • Bulgaria · Zornichka, Зорничка
  • Czechia · Uldiulan
  • Germany · Chlortalidon Axiromed, Chlortalidon Glenmark
  • Spain · Clortalidona Glenmark, Higrotona
  • United Kingdom (Northern Ireland) · Chlortalidone Glenmark Pharmaceuticals Europe, Chlortalidone Morningside Healthcare
  • Greece · Hygroton, Unidone
  • Croatia · Kataldi, Klortalidon Sandoz
  • Hungary · Uldiulan
  • Italy · Igroton
  • Poland · Hygroton, Uldiulan
  • Portugal · Clorotalidona Farmoz, Clorotalidona Glenmark
  • Romania · Uldiulan
  • Sweden · Hygropax
  • Slovakia · Uldiulan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b02ff3db-0faa-47f7-9c5a-fdcd259a3deb
GET /v1/drugs/b02ff3db-0faa-47f7-9c5a-fdcd259a3deb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131381_smpc.pdf",
  "strength": null,
  "atc_label": "Chlortalidone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131381",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "CHLOORTALIDON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131381.pdf",
  "authorised_at": "2024/05/13",
  "procedure_number": "NL/H/5822/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131381",
  "additional_monitoring": "N"
}

See everything about chlortalidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.